glp 1 fda ban is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Today, the FDA is announcing

Sugar-free, non-GMO, gluten-free, and naturally flavored for daily use.

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Understanding which compound may suit your body can help you choose treatment with greater comfort and better outcomes

Oh, and this is completely free too

CRAVINGS & APPETITE MANAGEMENT: Our unique formula helps support healthy snacking habits and portion control by promoting a sense of fullness and satisfaction

Alex Goldmark is Planet Moneys executive producer.Listen free at these links: Apple Podcasts, Spotify, the NPR app or anywhere you get podcasts.Find more Planet Money: Facebook / Instagram / TikTok / Our weekly Newsletter.Help support Planet Money and hear our bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney.Music: Source Audio - Subtly Silly Thug, Got The Moves, and Vive le Punk